Adoptive Cell Therapy Market by Bottom-up and Top-down Approaches (2023-2030) | GSK, AstraZeneca, Merck, Dey Pharma.
Adoptive cell therapy (ACT) is a kind of immunotherapy, in which T cells are genetically modified to express a chimeric antigen receptor or T cell receptor.